Inhibition of NAMPT has been reported to sensitize pancreatic cancer cells to gemcitabine chemotherapy by decreasing NAD levels and suppressing glycolytic activity [32,33,34,35]. This evidence concerns the gene NAMPT and familial pancreatic carcinoma.